化合物NQ301 T3757
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 130089-98-4 | ¥747.00 | 询底价 |
5 mg | 130089-98-4 | ¥498.00 | 询底价 |
1 mL | 130089-98-4 | ¥548.00 | 询底价 |
1 mg | 130089-98-4 | ¥225.00 | 询底价 |
500 mg | 130089-98-4 | ¥6,580.00 | 询底价 |
25 mg | 130089-98-4 | ¥1,250.00 | 询底价 |
100 mg | 130089-98-4 | ¥2,880.00 | 询底价 |
50 mg | 130089-98-4 | ¥1,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: NQ301
描述: NQ301 是一种抗血栓剂,能够抑制胶原蛋白激发的兔血小板聚集,IC50=10 mg/mL。
细胞实验: ished rabbit platelet suspension is challenged by addition of collagen (10 mg/mL), arachidonic acid (100 μM) or U46619 (1 μM). Concentration- response relationship is determined in the absence or presence of a range of concentrations of NQ301 (0, 0.25, 0.5, 0.75, 1 μM); aspirin-treated platelets (50 μM for 5 min) are used to prevent any possible contribution of endogenous arachidonic acid metabolites to platelet aggregation. The resulting aggregation, measured as the change in light transmission, is recorded for 5 min. The extent of platelet aggregation is expressed as % of the control[1].
激酶实验: Compounds are dissolved in DMSO (5 mg/mL) and diluted with PBS/EtOH (70:30).Kinetic analyses are carried out for TB5 and TB8. A set of Lineweaver–Burk plots are constructed in the absence and presence of various concentrations of compounds TB5 and TC8. The set consists of five graphs, each constructed by measuring MAO-B and MAO-A catalytic rates at different substrate concentrations (0.1-1 μM). The first Lineweaver–Burk plot is constructed in the absence of inhibitor, while the remaining four graphs are constructed in the presence of different concentrations of TB5 and TB8[1].
体外活性: NQ301 dose-dependently inhibits collagen (10 mg/mL, IC50: 0.60±0.02 μM), U46619 (1 mg/mL, IC50: 0.58±0.04 μM) and arachidonic acid (100 mg/mL, IC50: 0.78±0.04 μM) challenged rabbit platelet aggregation. NQ301 potently suppresses thromboxane B2 formation by platelets that are exposed to arachidonic acid in a concentration-dependent manner, but had no effect on the production of prostaglandin D2, indicating an inhibitory effect on thromboxane A2 synthase. NQ301 markedly inhibits the increase of cytosolic Ca2+ concentration and ATP secretion, and also markedly increases platelet cAMP levels in the activated platelets. The antiplatelet activity of NQ301 may be mediated by inhibition of cytosolic Ca2+ mobilization, enhancement of cAMP production and inhibition of ATP secretion in activated platelets.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 29 mg/mL
关键字: inhibit | Inhibitor | NQ 301 | NQ301 | NQ-301 | Thrombin
相关产品: RS-601 | Bivalirudin | Imitrodast | Thrombin receptor peptide ligand | Edoxaban Tosylate Monohydrate | NFPS | Eltrombopag | Dabigatran Etexilate Mesylate | Z-Gly-Pro-Arg-4MβNA | Dabigatran ethyl ester
相关库: Coagulation and Anticoagulation Compound Library | Anti-Metabolism Disease Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Endocrinology-Hormone Compound Library | Protease Inhibitor Library | Preclinical Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compound Library
化合物NQ301 T3757信息由TargetMol中国为您提供,如您想了解更多关于化合物NQ301 T3757报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途